Article
The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA - 1 Jul 2009
Zhu K, Beilby J, Dick I M, Devine A, Soós M, Prince R L
Abstract excerpt
SUMMARY: Few studies have evaluated the effects of homocysteine and methylenetetrahydrofolate reductase (MTHFR) genotype on age-related bone loss. In our 5-year cohort study with 1,213 women aged 70-85 years, high homocysteine is associated with greater hip bone loss but not fracture risk. The effect of MTHFR genotype on bone density and fracture is weak. INTRODUCTION: Previous studies on the effects of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
